Navid Sobhani

2.1k total citations · 1 hit paper
58 papers, 1.3k citations indexed

About

Navid Sobhani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Navid Sobhani has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Navid Sobhani's work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (9 papers) and Advanced Breast Cancer Therapies (8 papers). Navid Sobhani is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (9 papers) and Advanced Breast Cancer Therapies (8 papers). Navid Sobhani collaborates with scholars based in Italy, United States and United Kingdom. Navid Sobhani's co-authors include Giandomenico Roviello, Alberto D’Angelo, Daniele Generali, Daniele Generali, Yong Li, Raheleh Roudi, Silvia Paola Corona, Fabrizio Zanconati, Aram Davtyan and Marina Bortul and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Navid Sobhani

56 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects

2024 69 citations Bowen Lu, Siyuan Song et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Navid Sobhani Italy	21	607	556	416	294	249	58	1.3k
Maria J. de Miguel Spain	20	907 1.5×	566 1.0×	319 0.8×	562 1.9×	210 0.8×	99	1.7k
Yanbin Zhou China	22	389 0.6×	646 1.2×	264 0.6×	171 0.6×	248 1.0×	50	1.3k
Shoichiro Ohtani Japan	19	939 1.5×	371 0.7×	399 1.0×	177 0.6×	375 1.5×	92	1.4k
Hai Hu China	18	551 0.9×	666 1.2×	190 0.5×	222 0.8×	245 1.0×	33	1.3k
Tomer Cooks Israel	18	621 1.0×	965 1.7×	266 0.6×	470 1.6×	517 2.1×	36	1.8k
Pablo Matar Argentina	19	673 1.1×	469 0.8×	308 0.7×	413 1.4×	177 0.7×	37	1.3k
Miriam Redrado Spain	20	518 0.9×	544 1.0×	177 0.4×	233 0.8×	270 1.1×	39	1.1k
Khashayar Esfahani Canada	11	741 1.2×	374 0.7×	203 0.5×	430 1.5×	112 0.4×	37	1.3k
Laura Stanbery United States	17	557 0.9×	441 0.8×	198 0.5×	273 0.9×	242 1.0×	54	1.1k
Sreya Bagchi United States	10	984 1.6×	512 0.9×	370 0.9×	778 2.6×	186 0.7×	14	1.8k

Countries citing papers authored by Navid Sobhani

Since Specialization

Citations

This map shows the geographic impact of Navid Sobhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Sobhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Sobhani more than expected).

Fields of papers citing papers by Navid Sobhani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navid Sobhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Sobhani. The network helps show where Navid Sobhani may publish in the future.

Co-authorship network of co-authors of Navid Sobhani

This figure shows the co-authorship network connecting the top 25 collaborators of Navid Sobhani. A scholar is included among the top collaborators of Navid Sobhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Sobhani. Navid Sobhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sobhani, Navid, Alberto D’Angelo, Fernanda G. Kugeratski, et al.. (2025). Immune biomarkers for head and neck cancer. Cancer Immunology Immunotherapy. 75(1). 6–6. 1 indexed citations

Sobhani, Navid, Nicola Pavan, Daniele Generali, et al.. (2025). Circulating Cell-Free DNA Integrity for Breast and Prostate Cancer: What Is the Landscape for Clinical Management of the Most Common Cancers in Women and Men?. International Journal of Molecular Sciences. 26(3). 900–900. 3 indexed citations

Sobhani, Navid, et al.. (2025). Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma. Cancers. 17(4). 704–704. 1 indexed citations

D’Angelo, Alberto, et al.. (2024). Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathways. International Immunopharmacology. 143(Pt 1). 113265–113265. 1 indexed citations

Sobhani, Navid, et al.. (2024). Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion. Cancers. 16(17). 3089–3089. 10 indexed citations

Sobhani, Navid, et al.. (2024). Patient-Derived Organoids: A Game-Changer in Personalized Cancer Medicine. Stem Cell Reviews and Reports. 21(1). 211–225. 6 indexed citations

Lu, Bowen, Siyuan Song, Praveen Neeli, et al.. (2024). The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. Frontiers in Immunology. 15. 1332939–1332939. 69 indexed citations breakdown →

Ding, Jiage, Fei Zhu, Navid Sobhani, et al.. (2023). The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma. npj Vaccines. 8(1). 109–109. 5 indexed citations

Ganzinelli, Monica, Federica Guffanti, Navid Sobhani, et al.. (2023). Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair. Cancers. 15(17). 4309–4309. 2 indexed citations

10.

Safari, Fatemeh, et al.. (2023). Regulation of Cellular-Signaling Pathways by Mammalian Proteins Containing Bacterial EPIYA or EPIYA-Like Motifs Predicted to be Phosphorylated. DNA and Cell Biology. 43(2). 74–84. 1 indexed citations

11.

Neeli, Praveen, Dafei Chai, Xu Wang, et al.. (2023). Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2. iScience. 26(7). 107120–107120. 8 indexed citations

12.

Sobhani, Navid, Bruna Scaggiante, Dafei Chai, et al.. (2022). Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. Cancer Treatment Reviews. 109. 102429–102429. 58 indexed citations

13.

Roviello, Giandomenico, et al.. (2021). Advances in anti-BRAF therapies for lung cancer. Investigational New Drugs. 39(3). 879–890. 26 indexed citations

14.

Fan, Chunmei, Hongke Qu, Xu Wang, et al.. (2021). Cancer/testis antigens: from serology to mRNA cancer vaccine. Seminars in Cancer Biology. 76. 218–231. 45 indexed citations

15.

Sobhani, Navid, Praveen Neeli, Alberto D’Angelo, et al.. (2021). AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption. International Journal of Molecular Sciences. 22(11). 5515–5515. 39 indexed citations

16.

Schettini, Francesco, Navid Sobhani, Tiziana Triulzi, et al.. (2020). Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study. Breast Cancer Research and Treatment. 184(2). 421–431. 12 indexed citations

17.

Sobhani, Navid, Marianna Sirico, Daniele Generali, Fabrizio Zanconati, & Bruna Scaggiante. (2020). Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer. World Journal of Clinical Oncology. 11(7). 450–463. 10 indexed citations

18.

Roviello, Giandomenico, Navid Sobhani, Silvia Paola Corona, & Alberto D’Angelo. (2019). Corticosteroid switch after progression on abiraterone acetate plus prednisone. International Journal of Clinical Oncology. 25(2). 240–246. 6 indexed citations

19.

Sobhani, Navid, Daniele Generali, Alberto D’Angelo, Michele Aieta, & Giandomenico Roviello. (2018). Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer. Investigational New Drugs. 36(6). 1133–1137. 20 indexed citations

20.

Atyabi, Fatemeh, et al.. (2011). Increased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube. International Journal of Nanomedicine. 6. 705–705. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact